At the time of writing, Gossamer Bio Inc [GOSS] stock is trading at $2.34, up 7.83%. An important factor to consider is whether the stock is rising or falling in short-term value. The GOSS shares have gain 19.39% over the last week, with a monthly amount glided 31.46%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Gossamer Bio Inc [NASDAQ: GOSS] stock has seen the most recent analyst activity on July 14, 2025, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $11. Previously, Oppenheimer started tracking the stock with Outperform rating on June 25, 2024, and set its price target to $9. UBS downgraded its rating to a Neutral and decreased its price target to $1.25 on July 27, 2023. Raymond James downgraded its rating to a Mkt Perform. In a note dated December 07, 2022, SMBC Nikko downgraded a Neutral rating on this stock but restated the target price of $3.
For the past year, the stock price of Gossamer Bio Inc fluctuated between $0.66 and $2.23. Currently, Wall Street analysts expect the stock to reach $3.75 within the next 12 months. Gossamer Bio Inc [NASDAQ: GOSS] shares were valued at $2.34 at the most recent close of the market. An investor can expect a potential return of 60.26% based on the average GOSS price forecast.
Analyzing the GOSS fundamentals
According to Gossamer Bio Inc [NASDAQ:GOSS], the company’s sales were 40.24M for trailing twelve months, which represents an -88.01% plunge. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at -3.62%, Pretax Profit Margin comes in at -3.54%, and Net Profit Margin reading is -3.45%. To continue investigating profitability, this company’s Return on Assets is posted at -0.58, Equity is -17.75 and Total Capital is -0.78. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -4.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.21 points at the first support level, and at 2.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.41, and for the 2nd resistance point, it is at 2.48.
Ratios To Look Out For
It is important to note that Gossamer Bio Inc [NASDAQ:GOSS] has a current ratio of 4.40. On the other hand, the Quick Ratio is 4.40, and the Cash Ratio is 0.49. Considering the valuation of this stock, the price to sales ratio is 13.22.
Transactions by insiders
Recent insider trading involved Milligan Sandra, Director, that happened on Aug 19 ’25 when 26050.0 shares were purchased.
